SCHEMBL6711147

SCHEMBL6711147

NC(=O)C(CC=O)c1ccccc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
EPHX1 P07099 2/20 0.59
CYP2C19 P33261 3/20 0.50
CYP2D6 P10635 2/20 0.43
CYP1A2 P05177 1/20 0.42
PKM P14618 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
SLC6A3 Q01959 3/20 0.41
LMNA P02545 3/20 0.41
DRD3 P35462 2/20 0.41
MAPK1 P28482 2/20 0.41
ADORA3 P0DMS8 1/20 0.41
EDNRB P24530 1/20 0.41
MC4R P32245 1/20 0.41
MC3R P41968 1/20 0.41
DRD2 P14416 1/20 0.41
BCAT2 O15382 1/20 0.41
GABBR2 O75899 1/20 0.39
GABBR1 Q9UBS5 1/20 0.39
SRC P12931 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3308217 0.84 CYP2C19 (0.69) EPHX1CYP2C19CYP2D6CYP1A2SMN1; SMN2
SCHEMBL28223386 0.83 EPHX1 (0.58) EPHX1CYP2C19CYP2D6CYP1A2PKM
SCHEMBL3917092 0.83 CYP2C19 (0.44) EPHX1CYP2C19CYP2D6CYP1A2PKM
SCHEMBL6631805 0.83 CYP2C19 (0.73) EPHX1CYP2C19CYP2D6CYP1A2PKM
SCHEMBL6462542 0.81 EPHX1 (0.40) EPHX1GABBR2GABBR1
SCHEMBL8620344 0.81 CYP2C19 (0.71) EPHX1CYP2C19CYP2D6CYP1A2PKM
SCHEMBL29768390 0.81 EPHX1 (0.56) EPHX1CYP2C19CYP2D6CYP1A2PKM
SCHEMBL8624668 0.81 CYP2C19 (0.71) EPHX1CYP2C19CYP2D6CYP1A2PKM
SCHEMBL6820157 0.81 KMT2A (0.42) EPHX1CYP2C19CYP2D6CYP1A2LMNA
SCHEMBL6820001 0.81 ALOX5 (0.42) EPHX1CYP2C19PKMSMN1; SMN2NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-100410245-C Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents PHARMACIA & UPJOHN SPA (IT) 2008-08-13 CN disclosed
EP-1392315-A1 METHODS OF TREATING ALZHEIMER'S DISEASE Elan Pharmaceuticals, Inc. (US) 2004-03-03 EP disclosed
CN-1425009-A Arylmethyl-carbonylamino-thiazole derivatives and their use as antitumor agents PHARMACIA & UPJOHN SPA (IT) 2003-06-18 CN disclosed
WO-2002100410-A1 METHODS OF TREATING ALZHEIMER'S DISEASE ELAN PHARMACEUTICALS, INC. (US) 2002-12-19 WO disclosed